DoP Secy Bats for Collaboration to Ensure Medtech Growth May 9, 2024 DoP is boosting medical device export competitiveness through value-added manufacturing, targeting an import coverage ratio of 1.0.
NPPA Working on New Pricing Framework for Medical Devices April 29, 2024 Once the expert committee finalizes its recommendations, they will be forwarded to the Department of Pharmaceuticals (DoP) for further review.
Parl Panel Raises Concerns Over Regulatory Gap for Refurbished Medical Devices March 20, 2024 The Department-related Parliamentary Standing Committee on Chemicals and Fertilisers highlighted that the current laxity in regulation is compromising the standard of health services in the country.
Centre Forms Committee to Revise Drug & Medical Device Pricing Framework March 19, 2024 The committee has been specifically tasked with designing a price moderation framework for medical devices and emerging and precision therapies.
DoP Revises PLI Schemes for Bulk Drugs & Medical Devices March 15, 2024 The Department of Pharmaceuticals (DoP) has announced revision of production-linked incentive (PLI) guidelines to promote manufacturing of bulk drugs and medical devices.
AiMeD Demands Separate Pricing Policy for Medical Devices Industry March 15, 2024 The Association of Indian Medical Devices Industry (AiMeD) has underscored the necessity for a distinct pricing mechanism and regulatory framework for the medical devices sector.
DoP Forms Committee to Reform Drug Pricing Framework March 13, 2024 The objective is to strike a balance between ensuring the availability of essential medicines and incentivizing the industry for sustainable growth and exports.
DoP Revises PTUAS Guidelines to Support MSMEs March 12, 2024 The Department of Pharmaceuticals (DoP) has made substantial changes to the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) sub-scheme, with a focus on aiding MSMEs in the pharmaceutical sector.
Parl Panel Urges DoP to Expedite Recruitment of Medical Devices Officers March 4, 2024 The Department-related Parliamentary Standing Committee on Chemicals and Fertilizers has called upon the Department of Pharmaceuticals (DoP) to ensure the timely recruitment of officers to regulate the medical devices sector.
Parl Panel Urges DoP to Include Medical Devices in NLEM February 19, 2024 The Parliamentary Panel has recommended the Department of Pharmaceuticals (DoP) to include medium and high-end medical devices essential for critical care into the National List of Essential Medicines (NLEM).
Parl Panel Demands Increased Funding Outlay for Key Pharma Initiatives January 3, 2024 The Committee restated its prior recommendation, highlighting that the absence of funds for new schemes would negatively affect the development and expansion of the NIPER scheme.
Medical Devices PLI Scheme Records INR 879 Cr+ Investments till Sep 2023 January 2, 2024 Launched in July 2020, the PLI scheme seeks to bridge the manufacturing gap in medical devices within the country compared to other economies.